-
Something wrong with this record ?
Influence of competitive pulmonary blood flow on the bidirectional superior cavopulmonary shunt. A multi-institutional study
Steven A. Webber, Pavel Horvath, Jacques G. LeBlanc, Zdeněk Slavík, Robert K. Lamb, James L. Monro, Oleg Reich, Jaroslav Hruda, George G. S. Sandor, Barry R. Keeton, Anthony P. Salmon
Language English Country United States
Grant support
IZ2044
MZ0
CEP Register
IZ2048
MZ0
CEP Register
Digital library NLK
Full text - Část
Full text - Část
Source
Source
NLK
Free Medical Journals
from 1950 to 1 year ago
Open Access Digital Library
from 1950-01-01
Open Access Digital Library
from 1950-01-01
- MeSH
- Heart Bypass, Right methods mortality MeSH
- Child MeSH
- Adult MeSH
- Hemodynamics MeSH
- Infant MeSH
- Oxygen blood MeSH
- Humans MeSH
- Adolescent MeSH
- Follow-Up Studies MeSH
- Infant, Newborn MeSH
- Palliative Care MeSH
- Pulmonary Circulation MeSH
- Postoperative Complications MeSH
- Postoperative Period MeSH
- Child, Preschool MeSH
- Retrospective Studies MeSH
- Aging physiology MeSH
- Treatment Outcome MeSH
- Check Tag
- Child MeSH
- Adult MeSH
- Infant MeSH
- Humans MeSH
- Adolescent MeSH
- Male MeSH
- Infant, Newborn MeSH
- Child, Preschool MeSH
- Female MeSH
BACKGROUND: It is common practice to interrupt all alternative sources of pulmonary blood flow ("competitive flow") at the time of a bidirectional superior cavopulmonary anastomosis (BCPA), although the merits of this have not been systematically studied. METHODS AND RESULTS: We reviewed the early and medium-term clinical and hemodynamic findings in 108 consecutive patients 3 weeks to 25 years old (median, 1.9 years) undergoing BCPA at one of three institutions. Preoperatively, pulmonary blood flow was dependent on antegrade ventricular flow (n = 50), systemic-to-pulmonary shunts (n = 33), or mixed sources (n = 25). Postoperatively, competitive sources of pulmonary blood flow were left patent in 43 of 108 patients (40%). There were four early (3.7%) and four late deaths, none related to persistence of competitive flow. After BCPA, patients with competitive flow had significantly higher systemic oxygen saturations at 1 hour (85% versus 79%), 24 hours (84% versus 78%), and at hospital discharge (84% versus 78%) and required a shorter period of artificial ventilation (median, 9 versus 24 hours) and intensive care (median, 2 versus 4 days). Oxygen saturations at late follow-up (median, 2.8 years; range, 1 to 7) did not differ (83% versus 82%). No patient developed pulmonary arteriovenous malformations. CONCLUSIONS: Competitive flow is well tolerated in the short and medium term after BCPA, and early postoperative systemic oxygen saturations are improved. The long-term influence of competitive flow on pulmonary arterial growth, arteriovenous malformation development, and ventricular function warrants investigation.
Obsahuje tabulky
Bibliography, etc.Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12028738
- 003
- CZ-PrNML
- 005
- 20201130121640.0
- 007
- ta
- 008
- 120830s1995 xxu d f 000 0eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Webber, Steven A. $u Division of Pediatric Cardiology, Wessex Cardiothoracic Centre, Southampton, England.
- 245 10
- $a Influence of competitive pulmonary blood flow on the bidirectional superior cavopulmonary shunt. A multi-institutional study / $c Steven A. Webber, Pavel Horvath, Jacques G. LeBlanc, Zdeněk Slavík, Robert K. Lamb, James L. Monro, Oleg Reich, Jaroslav Hruda, George G. S. Sandor, Barry R. Keeton, Anthony P. Salmon
- 500 __
- $a Obsahuje tabulky
- 504 __
- $a Literatura $b 23
- 520 9_
- $a BACKGROUND: It is common practice to interrupt all alternative sources of pulmonary blood flow ("competitive flow") at the time of a bidirectional superior cavopulmonary anastomosis (BCPA), although the merits of this have not been systematically studied. METHODS AND RESULTS: We reviewed the early and medium-term clinical and hemodynamic findings in 108 consecutive patients 3 weeks to 25 years old (median, 1.9 years) undergoing BCPA at one of three institutions. Preoperatively, pulmonary blood flow was dependent on antegrade ventricular flow (n = 50), systemic-to-pulmonary shunts (n = 33), or mixed sources (n = 25). Postoperatively, competitive sources of pulmonary blood flow were left patent in 43 of 108 patients (40%). There were four early (3.7%) and four late deaths, none related to persistence of competitive flow. After BCPA, patients with competitive flow had significantly higher systemic oxygen saturations at 1 hour (85% versus 79%), 24 hours (84% versus 78%), and at hospital discharge (84% versus 78%) and required a shorter period of artificial ventilation (median, 9 versus 24 hours) and intensive care (median, 2 versus 4 days). Oxygen saturations at late follow-up (median, 2.8 years; range, 1 to 7) did not differ (83% versus 82%). No patient developed pulmonary arteriovenous malformations. CONCLUSIONS: Competitive flow is well tolerated in the short and medium term after BCPA, and early postoperative systemic oxygen saturations are improved. The long-term influence of competitive flow on pulmonary arterial growth, arteriovenous malformation development, and ventricular function warrants investigation.
- 590 __
- $a bohemika - dle Pubmed
- 650 02
- $a mladiství $7 D000293
- 650 02
- $a dospělí $7 D000328
- 650 02
- $a stárnutí $x fyziologie $7 D000375
- 650 02
- $a dítě $7 D002648
- 650 02
- $a předškolní dítě $7 D002675
- 650 02
- $a ženské pohlaví $7 D005260
- 650 02
- $a následné studie $7 D005500
- 650 02
- $a bypass pravého srdce $x metody $x mortalita $7 D018610
- 650 02
- $a hemodynamika $7 D006439
- 650 02
- $a lidé $7 D006801
- 650 02
- $a kojenec $7 D007223
- 650 02
- $a novorozenec $7 D007231
- 650 02
- $a mužské pohlaví $7 D008297
- 650 02
- $a kyslík $x krev $7 D010100
- 650 02
- $a paliativní péče $7 D010166
- 650 02
- $a pooperační komplikace $7 D011183
- 650 02
- $a pooperační období $7 D011184
- 650 02
- $a plicní oběh $7 D011652
- 650 02
- $a retrospektivní studie $7 D012189
- 650 02
- $a výsledek terapie $7 D016896
- 700 1_
- $a Horváth, Pavel, $d 1953-1994 $7 nlk20050170350 $u The Kardiocentrum, Prague, Czech Republic
- 700 1_
- $a LeBlanc, Jacques G.
- 700 1_
- $a Slavík, Zdeněk $7 xx0156392
- 700 1_
- $a Lamb, Robert K.
- 700 1_
- $a Monro, James L., $d 1939-2013 $7 xx0254672
- 700 1_
- $a Reich, Oleg, $d 1954- $7 xx0037559
- 700 1_
- $a Hruda, Jaroslav $7 xx0060177
- 700 1_
- $a Sandor, George G. S.
- 700 1_
- $a Keeton, Barry R.
- 700 1_
- $a Salmon, Anthony P.
- 773 0_
- $t Circulation $x 0009-7322 $g Roč. 92, č. 9 Suppl (1995), s. II279-286 $p Circulation $w MED00001091
- 773 0_
- $p Circulation $g 92(9 Suppl):II279-86, 1995 Nov 1 $x 0009-7322
- 910 __
- $a ABA008 $b A 716 $y 2 $z 0
- 990 __
- $a 20120830152042 $b ABA008
- 991 __
- $a 20201130121607 $b ABA008
- 999 __
- $a ok $b bmc $g 950800 $s 786094
- BAS __
- $a 3
- BMC __
- $a 1995 $b 92 $c 9 Suppl $d II279-286 $x MED00001091 $i 0009-7322 $m Circulation (New York, N.Y.) $n Circulation (New York)
- GRA __
- $a IZ2044 $p MZ0
- GRA __
- $a IZ2048 $p MZ0
- LZP __
- $a 2012-08/gvbo